[go: up one dir, main page]

Lovell et al., 2012 - Google Patents

Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles

Lovell et al., 2012

View PDF
Document ID
17463299188358047452
Author
Lovell J
Jin C
Huynh E
MacDonald T
Cao W
Zheng G
Publication year
Publication venue
Angewandte Chemie-International Edition

External Links

Snippet

We recently reported that porphyrin–phospholipid conjugates can self-assemble into “porphysome” nanovesicles composed of a dense porphyrin bilayer.[1] Porphysomes exhibit structurally driven nanoscale optical properties and have intrinsic capabilities for multimodal …
Continue reading at www.acsu.buffalo.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
    • A61K47/48046—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a lipid, e.g. a triglyceride; the modifying agent being a polyamine, e.g. spermine or spermidine
    • A61K47/48053—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a lipid, e.g. a triglyceride; the modifying agent being a polyamine, e.g. spermine or spermidine the modifying agent being a phospholipid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides

Similar Documents

Publication Publication Date Title
Lovell et al. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles
CA2837901C (en) Method for the enzymatic preparation of a composition of porphyrin-phospholipid conjugates with defined regioisomeric ratios
Staroń et al. Lactose esters: Synthesis and biotechnological applications
Kumar et al. Synthesis of macromolecular systems via lipase catalyzed biocatalytic reactions: applications and future perspectives
Troutier et al. New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles
Cao et al. Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging
Brard et al. Synthesis of archaeal bipolar lipid analogues: a way to versatile drug/gene delivery systems
Massiot et al. Newly synthesized lipid–porphyrin conjugates: evaluation of their self‐assembling properties, their miscibility with phospholipids and their photodynamic activity in vitro
Grinberg et al. Asymmetric bolaamphiphiles from vernonia oil designed for drug delivery
JP2024521852A (en) MC3 lipids and their use in the preparation of lipid nanoparticles
Noro et al. Ultrasound-assisted biosynthesis of novel methotrexate-conjugates
Furukawa et al. Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake
US20100086972A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
Yin et al. High-yield synthesis of phosphatidylserine in a well-designed mixed micellar system
AM et al. Transfection efficacy and drug release depends upon the PEG derivative in cationic lipoplexes: Evaluation in 3D in vitro model and in vivo
US20240216291A1 (en) Nucleic Acid Containing Nanoparticles
Drescher et al. Impact of headgroup asymmetry and protonation state on the aggregation behavior of a new type of glycerol diether bolalipid
Belhaj et al. Galactolipase activity of Talaromyces thermophilus lipase on galactolipid micelles, monomolecular films and UV-absorbing surface-coated substrate
Portilla-Arias et al. Nanoconjugate Platforms Development Based in Poly (β, L‐Malic Acid) Methyl Esters for Tumor Drug Delivery
Stern et al. Steric environment around acetylcholine head groups of bolaamphiphilic nanovesicles influences the release rate of encapsulated compounds
Dewa et al. Novel Polyamine− Dialkyl Phosphate Conjugates for Gene Carriers. Facile Synthetic Route via an Unprecedented Dialkyl Phosphate
JP5010887B2 (en) Boron-containing compound and liposome using the same
Wongthongdee et al. Green formulation strategy for preparing oil-in-water emulsions via lipase-catalyzed transesterification
Lee et al. Lysolecithin-fatty acid liposomes as novel antibacterial agents to suppress the growth of periodontal Porphyromonas gingivalis
Aissa et al. Monolayer properties of synthesized tyrosyl esters